Latest Regenerative Wound News

The latest additions aim to support clinicians treating smaller wounds, enhancing flexibility and workflow in surgical wound care.
The new agreement enables Vizient members broader access to BioTissue’s amniotic membrane products for diverse clinical applications.
The company will produce its FDA-approved diabetic foot ulcer product and others at the new facility, creating over 200 full-time jobs.

Stay updated on Regenerative Medicine